A Comparative Analysis of Mental Health Parameters in Patients with Malignant, Intermediate, and Benign Soft Tissue Tumors: A Comprehensive Approach

• Conditions: Patients with soft-tissue tumorsORPHA:873 Desmoid tumor; D48.1; Connective and other soft tissue

• Registration Number: DRKS00032488
• Lead Sponsor: Heinrich-Heine Universität Düsseldorf Klinische Psychologie Institut für Experimentelle Psychologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-08-17
• Study Completion: 2024-01-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 426

Inclusion Criteria

Patients who have/had any kind of benign, intermediate or malignant soft-tissue tumor
-sufficient in English
-sufficient in handling a smartphone, tablet or computer
-stable internet connection

Exclusion Criteria

-younger than 18 years
-patients who were diagnosed with several tumors such as a malignant and benign or indermediate tumor
-patients who were diagnosed with a mental disorder prior to the oncological diagnosis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Differences between benign, intermediate and malignant soft-tissue tumor patients with regard to patients´ mental health and coping with the disease. <br>The survey measures stress coping using the Brief COPE, depression using the Patient Health Questionnaire (PHQ-9), quality of life using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), resilience using the Brief Resilience Scale (BRS), emotionality using the Positive and Negative Affect Schedule (PANAS), need for psychosocial support using the Hornheider Screening Instrument (HSI), suffering using the Suffering Assessment Questionnaire (SAQ), fear of progression using the Fear of Progression Questionnaire (FOP) and psychological strain using the Kessler Psychological Distress Scale (K10).

Secondary Outcome Measures

Name	Time	Method
Disease specific questions and questions about the medical and psychosocial support are supposed to shed light on whether the emotional strain in soft-tissue tumor patients is only determined by malignancy or if aspects such as uncertainty and inexperience with rare diseases have an influence too.